CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis

OSL:CONTX • SE0014731154

3.21 NOK
+0.02 (+0.63%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

CONTX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 10 industry peers in the Health Care Technology industry. CONTX has an average financial health and profitability rating. CONTX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CONTX had positive earnings in the past year.
  • CONTX had a positive operating cash flow in the past year.
  • Of the past 5 years CONTX 4 years were profitable.
  • In the past 5 years CONTX always reported a positive cash flow from operatings.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • CONTX has a Return On Assets (3.07%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 3.95%, CONTX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • CONTX has a Return On Invested Capital of 2.67%. This is in the lower half of the industry: CONTX underperforms 60.00% of its industry peers.
  • CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 8.41%.
  • The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(2.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROIC 2.67%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • With a Profit Margin value of 3.17%, CONTX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • CONTX's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 2.90%, CONTX is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • CONTX's Operating Margin has improved in the last couple of years.
  • CONTX has a better Gross Margin (97.62%) than 90.00% of its industry peers.
  • In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
Industry RankSector Rank
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • CONTX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CONTX has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, CONTX has a worse debt to assets ratio.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • The Debt to FCF ratio of CONTX is 5.01, which is a neutral value as it means it would take CONTX, 5.01 years of fcf income to pay off all of its debts.
  • CONTX has a Debt to FCF ratio (5.01) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
  • CONTX has a Debt to Equity ratio of 0.07. This is in the better half of the industry: CONTX outperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Altman-Z N/A
ROIC/WACC0.3
WACC8.96%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.79. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of CONTX (4.79) is better than 90.00% of its industry peers.
  • CONTX has a Quick Ratio of 4.70. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX has a better Quick ratio (4.70) than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 4.7
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for CONTX have decreased strongly by -83.70% in the last year.
  • CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.26% yearly.
  • The Revenue for CONTX has decreased by -13.08% in the past year. This is quite bad
  • The Revenue has been growing slightly by 6.51% on average over the past years.
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%

3.2 Future

  • Based on estimates for the next years, CONTX will show a decrease in Earnings Per Share. The EPS will decrease by -7.44% on average per year.
  • CONTX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.43% yearly.
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y-1.43%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 64.20, the valuation of CONTX can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as CONTX.
  • The average S&P500 Price/Earnings ratio is at 27.16. CONTX is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 26.74, CONTX can be considered very expensive at the moment.
  • CONTX's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, CONTX is valued at the same level.
Industry RankSector Rank
PE 64.2
Fwd PE 26.74
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CONTX is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX indicates a slightly more expensive valuation: CONTX is more expensive than 60.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 140.11
EV/EBITDA 15.78
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • CONTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as CONTX's earnings are expected to decrease with -7.44% in the coming years.
PEG (NY)N/A
PEG (5Y)2.36
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.02, CONTX pays a better dividend. On top of this CONTX pays more dividend than 90.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CONTX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONTEXTVISION AB

OSL:CONTX (2/17/2026, 7:00:00 PM)

3.21

+0.02 (+0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap248.36M
Revenue(TTM)112.76M
Net Income(TTM)3.58M
Analysts40
Price Target4.08 (27.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.52%
Min Revenue beat(2)-22.13%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.52%
Valuation
Industry RankSector Rank
PE 64.2
Fwd PE 26.74
P/S 2.08
P/FCF 140.11
P/OCF 26.39
P/B 2.59
P/tB 2.66
EV/EBITDA 15.78
EPS(TTM)0.05
EY1.56%
EPS(NY)0.12
Fwd EY3.74%
FCF(TTM)0.02
FCFY0.71%
OCF(TTM)0.12
OCFY3.79%
SpS1.54
BVpS1.24
TBVpS1.21
PEG (NY)N/A
PEG (5Y)2.36
Graham Number1.18
Profitability
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROCE 3.38%
ROIC 2.67%
ROICexc 8.83%
ROICexgc 9.67%
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
FCFM 1.48%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Debt/EBITDA 0.55
Cap/Depr 92.01%
Cap/Sales 6.39%
Interest Coverage 250
Cash Conversion 79.95%
Profit Quality 46.76%
Current Ratio 4.79
Quick Ratio 4.7
Altman-Z N/A
F-Score5
WACC8.96%
ROIC/WACC0.3
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y-1.43%
EBIT growth 1Y-87.72%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-95.22%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-79.63%
OCF growth 3Y51.49%
OCF growth 5Y5.6%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 2 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -103.45% in the next year.